2008
DOI: 10.1053/j.gastro.2008.01.012
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

24
680
10
49

Year Published

2008
2008
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 931 publications
(763 citation statements)
references
References 34 publications
24
680
10
49
Order By: Relevance
“…Then a logistic regression expressed as aOR, was used to determine the association between the concentration of inflammatory markers with each parasite or parasite group separately (STHs, A. lumbricoides , protozoa, E. coli, E. nana and multiple infection) comparing them to parasite‐free children. To decrease the occurrence of type 1 errors due to multiple comparisons, the Bonferroni‐adjusted test of significance was used 27. Body fat (%), sex (m/f), age (y), mother's education level (y) and malnutrition (stunted or underweight) were included in the model as confounders, as these factors are associated with both elevated inflammatory markers and intestinal parasitic infection 28…”
Section: Methodsmentioning
confidence: 99%
“…Then a logistic regression expressed as aOR, was used to determine the association between the concentration of inflammatory markers with each parasite or parasite group separately (STHs, A. lumbricoides , protozoa, E. coli, E. nana and multiple infection) comparing them to parasite‐free children. To decrease the occurrence of type 1 errors due to multiple comparisons, the Bonferroni‐adjusted test of significance was used 27. Body fat (%), sex (m/f), age (y), mother's education level (y) and malnutrition (stunted or underweight) were included in the model as confounders, as these factors are associated with both elevated inflammatory markers and intestinal parasitic infection 28…”
Section: Methodsmentioning
confidence: 99%
“…39 In previous studies, treatment with a combination of immunosuppressants was identified as the most consistent factor related to the risk of de novo and ⁄ or reactivation of opportunistic infections in IBD. 40,41 The largest study assessing outcome of HBV infection in patients with IBD and its relation to immunosuppressive therapy has recently been published (REPENTINA 2). 36 The study sample comprised patients with IBD and viral hepatitis from 19 Spanish hospitals.…”
Section: Which Ibd Patients Should Be Screened For Prior Hbv ⁄ Hcv Exmentioning
confidence: 99%
“…Even after extensive world-wide experience with anti-TNF-therapy in IBD and other indications, such as rheumatological or dermatological diseases, there still is some uncertainty about potential risks [9][10][11][12][13] . In the last few years, there has been an increasing trend towards an earlier introduction of TNF-inhibitors (which is associated with a better efficacy 14 ) either via a rapid step up 15,16 or top down 17 , to avoid prolonged steroid exposure and minimizing CDassociated morbidity and the need for surgery.…”
Section: Introductionmentioning
confidence: 99%